nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—CYP3A5—Beclomethasone—psoriasis	0.0803	0.122	CbGbCtD
Teniposide—ABCG2—Mycophenolate mofetil—psoriasis	0.0577	0.0877	CbGbCtD
Teniposide—ABCG2—Hydrocortisone—psoriasis	0.0463	0.0704	CbGbCtD
Teniposide—ABCG2—Cyclosporine—psoriasis	0.0437	0.0665	CbGbCtD
Teniposide—CYP3A5—Mycophenolate mofetil—psoriasis	0.032	0.0486	CbGbCtD
Teniposide—CYP2C19—Cholecalciferol—psoriasis	0.0298	0.0452	CbGbCtD
Teniposide—ABCG2—Dexamethasone—psoriasis	0.0288	0.0438	CbGbCtD
Teniposide—CYP3A4—Calcitriol—psoriasis	0.0279	0.0424	CbGbCtD
Teniposide—CYP3A5—Hydrocortisone—psoriasis	0.0257	0.039	CbGbCtD
Teniposide—CYP2C9—Cholecalciferol—psoriasis	0.0247	0.0376	CbGbCtD
Teniposide—CYP3A5—Cyclosporine—psoriasis	0.0242	0.0368	CbGbCtD
Teniposide—ABCG2—Methotrexate—psoriasis	0.0232	0.0352	CbGbCtD
Teniposide—CYP3A4—Methoxsalen—psoriasis	0.0217	0.033	CbGbCtD
Teniposide—CYP2C19—Prednisone—psoriasis	0.0206	0.0313	CbGbCtD
Teniposide—CYP2C19—Cyclosporine—psoriasis	0.0195	0.0297	CbGbCtD
Teniposide—CYP2C9—Cyclosporine—psoriasis	0.0163	0.0247	CbGbCtD
Teniposide—CYP3A5—Dexamethasone—psoriasis	0.016	0.0242	CbGbCtD
Teniposide—CYP3A4—Cholecalciferol—psoriasis	0.0144	0.0219	CbGbCtD
Teniposide—CYP2C19—Dexamethasone—psoriasis	0.0129	0.0196	CbGbCtD
Teniposide—CYP3A4—Mycophenolate mofetil—psoriasis	0.0125	0.0189	CbGbCtD
Teniposide—CYP3A4—Triamcinolone—psoriasis	0.0125	0.0189	CbGbCtD
Teniposide—CYP2C9—Dexamethasone—psoriasis	0.0107	0.0163	CbGbCtD
Teniposide—CYP3A4—Betamethasone—psoriasis	0.0107	0.0163	CbGbCtD
Teniposide—CYP3A4—Prednisolone—psoriasis	0.0106	0.016	CbGbCtD
Teniposide—CYP3A4—Hydrocortisone—psoriasis	0.01	0.0152	CbGbCtD
Teniposide—CYP3A4—Prednisone—psoriasis	0.00997	0.0151	CbGbCtD
Teniposide—ABCC6—dermis—psoriasis	0.00981	0.746	CbGeAlD
Teniposide—CYP3A4—Cyclosporine—psoriasis	0.00945	0.0144	CbGbCtD
Teniposide—CYP3A4—Dexamethasone—psoriasis	0.00622	0.00945	CbGbCtD
Teniposide—NCOA1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.00247	0.018	CbGpPWpGaD
Teniposide—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00239	0.0174	CbGpPWpGaD
Teniposide—NCOA1—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.00232	0.0169	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.0023	0.0167	CbGpPWpGaD
Teniposide—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00218	0.0159	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional activation of mitochondrial biogenesis—CARM1—psoriasis	0.00211	0.0154	CbGpPWpGaD
Teniposide—NCOA3—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.00211	0.0154	CbGpPWpGaD
Teniposide—NCOA1—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.00196	0.0143	CbGpPWpGaD
Teniposide—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00191	0.014	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.0019	0.0139	CbGpPWpGaD
Teniposide—NCOA1—Regulation of Androgen receptor activity—REL—psoriasis	0.00188	0.0137	CbGpPWpGaD
Teniposide—NCOA1—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.00185	0.0135	CbGpPWpGaD
Teniposide—NCOA1—Regulation of Androgen receptor activity—CARM1—psoriasis	0.00185	0.0135	CbGpPWpGaD
Teniposide—NCOA1—Mitochondrial biogenesis—CARM1—psoriasis	0.00183	0.0133	CbGpPWpGaD
Teniposide—NCOA1—Circadian Clock—CARM1—psoriasis	0.0018	0.0131	CbGpPWpGaD
Teniposide—NCOA1—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.00174	0.0127	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.00166	0.0121	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.00165	0.012	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—CP—psoriasis	0.00163	0.0119	CbGpPWpGaD
Teniposide—NCOA1—tendon—psoriasis	0.00159	0.121	CbGeAlD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.00155	0.0113	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.0015	0.011	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—CARM1—psoriasis	0.00148	0.0108	CbGpPWpGaD
Teniposide—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00148	0.0108	CbGpPWpGaD
Teniposide—NCOA1—Biological oxidations—CYP2S1—psoriasis	0.00148	0.0108	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—REL—psoriasis	0.00142	0.0104	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.00137	0.01	CbGpPWpGaD
Teniposide—NCOA1—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00136	0.00995	CbGpPWpGaD
Teniposide—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00135	0.00984	CbGpPWpGaD
Teniposide—NCOA3—PPARA activates gene expression—CARM1—psoriasis	0.00125	0.00911	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—CARM1—psoriasis	0.00122	0.00893	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.00122	0.00892	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL13—psoriasis	0.00121	0.00885	CbGpPWpGaD
Teniposide—NCOA3—tendon—psoriasis	0.00111	0.0841	CbGeAlD
Teniposide—NCOA1—Orphan transporters—CARM1—psoriasis	0.00108	0.00788	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—CRP—psoriasis	0.00107	0.0078	CbGpPWpGaD
Teniposide—NCOA1—PPARA activates gene expression—CARM1—psoriasis	0.00103	0.00754	CbGpPWpGaD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.00102	0.00745	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.00101	0.00738	CbGpPWpGaD
Teniposide—TOP2A—G0 and Early G1—PCNA—psoriasis	0.00095	0.00693	CbGpPWpGaD
Teniposide—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00089	0.00649	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000845	0.00616	CbGpPWpGaD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000842	0.00614	CbGpPWpGaD
Teniposide—NCOA1—Organelle biogenesis and maintenance—CARM1—psoriasis	0.000828	0.00604	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—TYK2—psoriasis	0.000799	0.00583	CbGpPWpGaD
Teniposide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000795	0.0058	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.000794	0.00579	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	0.000788	0.00575	CbGpPWpGaD
Teniposide—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000784	0.00572	CbGpPWpGaD
Teniposide—NCOA3—FOXA1 transcription factor network—JUN—psoriasis	0.000768	0.0056	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	0.000767	0.00559	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000743	0.00542	CbGpPWpGaD
Teniposide—ABCG2—Iron uptake and transport—CP—psoriasis	0.000741	0.00541	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL4—psoriasis	0.000738	0.00539	CbGpPWpGaD
Teniposide—NCOA1—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000724	0.00528	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000709	0.00517	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000697	0.00508	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000692	0.00505	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000692	0.00504	CbGpPWpGaD
Teniposide—NCOA1—Notch-mediated HES/HEY network—CD4—psoriasis	0.000673	0.00491	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—LEP—psoriasis	0.000671	0.00489	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.000657	0.00479	CbGpPWpGaD
Teniposide—TOP2A—tendon—psoriasis	0.000649	0.0494	CbGeAlD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—psoriasis	0.000646	0.00471	CbGpPWpGaD
Teniposide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000644	0.0047	CbGpPWpGaD
Teniposide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000614	0.00448	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000613	0.00447	CbGpPWpGaD
Teniposide—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000606	0.00442	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	0.000587	0.00428	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—SOCS1—psoriasis	0.000585	0.00427	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000572	0.00417	CbGpPWpGaD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.000569	0.00415	CbGpPWpGaD
Teniposide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00056	0.00409	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—STAT3—psoriasis	0.000559	0.00408	CbGpPWpGaD
Teniposide—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000553	0.00403	CbGpPWpGaD
Teniposide—NCOA1—Regulation of Androgen receptor activity—JUN—psoriasis	0.000547	0.00399	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000526	0.00384	CbGpPWpGaD
Teniposide—NCOA1—Notch-mediated HES/HEY network—STAT3—psoriasis	0.000521	0.0038	CbGpPWpGaD
Teniposide—NCOA3—PPARA activates gene expression—PPARG—psoriasis	0.00052	0.00379	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000509	0.00371	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—TARS—psoriasis	0.000505	0.00368	CbGpPWpGaD
Teniposide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000498	0.00363	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—PCNA—psoriasis	0.000486	0.00354	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.000472	0.00344	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.00047	0.00343	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—JUN—psoriasis	0.000459	0.00335	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000459	0.00335	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000458	0.00334	CbGpPWpGaD
Teniposide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000454	0.00331	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	0.000446	0.00326	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—JUN—psoriasis	0.000437	0.00319	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—LEP—psoriasis	0.000432	0.00315	CbGpPWpGaD
Teniposide—TOP2A—Methyltestosterone—Hydrocortisone—psoriasis	0.00043	0.258	CbGdCrCtD
Teniposide—NCOA1—PPARA activates gene expression—PPARG—psoriasis	0.00043	0.00314	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000421	0.00307	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	0.000415	0.00303	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	0.000401	0.00293	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—NFKB1—psoriasis	0.000399	0.00291	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—IL6—psoriasis	0.000391	0.00285	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.000391	0.00285	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	0.00039	0.00284	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—JUN—psoriasis	0.000386	0.00281	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—CP—psoriasis	0.000383	0.00279	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—STAT3—psoriasis	0.000378	0.00276	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—PPARG—psoriasis	0.000376	0.00274	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CARM1—psoriasis	0.000376	0.00274	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	0.000371	0.00271	CbGpPWpGaD
Teniposide—TOP2A—Methyltestosterone—Prednisone—psoriasis	0.000371	0.222	CbGdCrCtD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000369	0.00269	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	0.000367	0.00268	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—CARM1—psoriasis	0.000365	0.00266	CbGpPWpGaD
Teniposide—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000365	0.00266	CbGpPWpGaD
Teniposide—TOP2A—Methyltestosterone—Prednisolone—psoriasis	0.000362	0.217	CbGdCrCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—JUN—psoriasis	0.000361	0.00264	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—NDUFA5—psoriasis	0.00036	0.00262	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—STAT3—psoriasis	0.000358	0.00261	CbGpPWpGaD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000351	0.00256	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.00035	0.00255	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000342	0.0025	CbGpPWpGaD
Teniposide—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000338	0.00246	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000335	0.00245	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—CARM1—psoriasis	0.00033	0.00241	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—STAT3—psoriasis	0.000313	0.00228	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CARM1—psoriasis	0.000311	0.00227	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CYP2S1—psoriasis	0.000306	0.00223	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	0.000304	0.00222	CbGpPWpGaD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0003	0.00218	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—NDUFA5—psoriasis	0.000298	0.00217	CbGpPWpGaD
Teniposide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000295	0.00216	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—psoriasis	0.000294	0.00214	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.00029	0.00212	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—JUN—psoriasis	0.000286	0.00209	CbGpPWpGaD
Teniposide—Hypotension—Mycophenolic acid—psoriasis	0.000286	0.00151	CcSEcCtD
Teniposide—Arrhythmia—Prednisolone—psoriasis	0.000283	0.00149	CcSEcCtD
Teniposide—TOP2A—Norethindrone—Hydrocortisone—psoriasis	0.000281	0.168	CbGdCrCtD
Teniposide—Anaemia—Cyclosporine—psoriasis	0.000281	0.00148	CcSEcCtD
Teniposide—Agitation—Cyclosporine—psoriasis	0.000279	0.00147	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000277	0.00202	CbGpPWpGaD
Teniposide—Arrhythmia—Hydrocortisone—psoriasis	0.000277	0.00146	CcSEcCtD
Teniposide—Nausea—Acitretin—psoriasis	0.000277	0.00146	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—CP—psoriasis	0.000277	0.00202	CbGpPWpGaD
Teniposide—Nausea—Fluocinolone Acetonide—psoriasis	0.000276	0.00145	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.000276	0.00201	CbGpPWpGaD
Teniposide—Anaemia—Mycophenolate mofetil—psoriasis	0.000274	0.00144	CcSEcCtD
Teniposide—Dyspnoea—Mycophenolic acid—psoriasis	0.000273	0.00144	CcSEcCtD
Teniposide—Agitation—Mycophenolate mofetil—psoriasis	0.000272	0.00143	CcSEcCtD
Teniposide—Leukopenia—Cyclosporine—psoriasis	0.000272	0.00143	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—JUN—psoriasis	0.000271	0.00197	CbGpPWpGaD
Teniposide—Hypersensitivity—Hydroxyurea—psoriasis	0.000269	0.00142	CcSEcCtD
Teniposide—Neutropenia—Prednisone—psoriasis	0.000269	0.00142	CcSEcCtD
Teniposide—Decreased appetite—Mycophenolic acid—psoriasis	0.000266	0.0014	CcSEcCtD
Teniposide—Haemoglobin—Betamethasone—psoriasis	0.000266	0.0014	CcSEcCtD
Teniposide—Haemoglobin—Dexamethasone—psoriasis	0.000266	0.0014	CcSEcCtD
Teniposide—Leukopenia—Mycophenolate mofetil—psoriasis	0.000265	0.0014	CcSEcCtD
Teniposide—Haemorrhage—Dexamethasone—psoriasis	0.000265	0.00139	CcSEcCtD
Teniposide—Haemorrhage—Betamethasone—psoriasis	0.000265	0.00139	CcSEcCtD
Teniposide—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000265	0.00193	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000264	0.00192	CbGpPWpGaD
Teniposide—Asthenia—Hydroxyurea—psoriasis	0.000262	0.00138	CcSEcCtD
Teniposide—Hypertension—Cyclosporine—psoriasis	0.000262	0.00138	CcSEcCtD
Teniposide—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000261	0.0019	CbGpPWpGaD
Teniposide—Arrhythmia—Triamcinolone—psoriasis	0.000261	0.00137	CcSEcCtD
Teniposide—Chest pain—Cyclosporine—psoriasis	0.000258	0.00136	CcSEcCtD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000257	0.00188	CbGpPWpGaD
Teniposide—Liver function test abnormal—Methotrexate—psoriasis	0.000257	0.00135	CcSEcCtD
Teniposide—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000257	0.00187	CbGpPWpGaD
Teniposide—Hypertension—Mycophenolate mofetil—psoriasis	0.000256	0.00135	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000255	0.00186	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CYP2S1—psoriasis	0.000253	0.00185	CbGpPWpGaD
Teniposide—Feeling abnormal—Mycophenolic acid—psoriasis	0.000252	0.00133	CcSEcCtD
Teniposide—Chest pain—Mycophenolate mofetil—psoriasis	0.000252	0.00133	CcSEcCtD
Teniposide—Neuropathy peripheral—Prednisone—psoriasis	0.000252	0.00133	CcSEcCtD
Teniposide—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.00025	0.00132	CcSEcCtD
Teniposide—Diarrhoea—Hydroxyurea—psoriasis	0.00025	0.00132	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—VEGFA—psoriasis	0.00025	0.00182	CbGpPWpGaD
Teniposide—Confusional state—Cyclosporine—psoriasis	0.00025	0.00132	CcSEcCtD
Teniposide—Oedema—Cyclosporine—psoriasis	0.000248	0.0013	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000246	0.0018	CbGpPWpGaD
Teniposide—Infection—Cyclosporine—psoriasis	0.000246	0.0013	CcSEcCtD
Teniposide—Confusional state—Mycophenolate mofetil—psoriasis	0.000244	0.00128	CcSEcCtD
Teniposide—Thrombocytopenia—Cyclosporine—psoriasis	0.000243	0.00128	CcSEcCtD
Teniposide—Body temperature increased—Mycophenolic acid—psoriasis	0.000242	0.00128	CcSEcCtD
Teniposide—Abdominal pain—Mycophenolic acid—psoriasis	0.000242	0.00128	CcSEcCtD
Teniposide—Oedema—Mycophenolate mofetil—psoriasis	0.000242	0.00127	CcSEcCtD
Teniposide—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000241	0.00176	CbGpPWpGaD
Teniposide—Infection—Mycophenolate mofetil—psoriasis	0.00024	0.00126	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	0.00024	0.00175	CbGpPWpGaD
Teniposide—Hyperhidrosis—Cyclosporine—psoriasis	0.000239	0.00126	CcSEcCtD
Teniposide—Hypertension—Prednisolone—psoriasis	0.000238	0.00126	CcSEcCtD
Teniposide—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000238	0.00174	CbGpPWpGaD
Teniposide—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000237	0.00125	CcSEcCtD
Teniposide—Arrhythmia—Dexamethasone—psoriasis	0.000237	0.00125	CcSEcCtD
Teniposide—Arrhythmia—Betamethasone—psoriasis	0.000237	0.00125	CcSEcCtD
Teniposide—Anorexia—Cyclosporine—psoriasis	0.000236	0.00124	CcSEcCtD
Teniposide—Tachycardia—Mycophenolate mofetil—psoriasis	0.000236	0.00124	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—STAT3—psoriasis	0.000234	0.00171	CbGpPWpGaD
Teniposide—Alopecia—Betamethasone—psoriasis	0.000234	0.00123	CcSEcCtD
Teniposide—Alopecia—Dexamethasone—psoriasis	0.000234	0.00123	CcSEcCtD
Teniposide—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000234	0.00123	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.000233	0.0017	CbGpPWpGaD
Teniposide—Hypertension—Hydrocortisone—psoriasis	0.000233	0.00123	CcSEcCtD
Teniposide—Vomiting—Hydroxyurea—psoriasis	0.000232	0.00122	CcSEcCtD
Teniposide—Haemoglobin—Prednisone—psoriasis	0.000232	0.00122	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—STAT3—psoriasis	0.000231	0.00168	CbGpPWpGaD
Teniposide—Haemorrhage—Prednisone—psoriasis	0.000231	0.00121	CcSEcCtD
Teniposide—Rash—Hydroxyurea—psoriasis	0.000231	0.00121	CcSEcCtD
Teniposide—Anorexia—Mycophenolate mofetil—psoriasis	0.00023	0.00121	CcSEcCtD
Teniposide—Dermatitis—Hydroxyurea—psoriasis	0.00023	0.00121	CcSEcCtD
Teniposide—Headache—Hydroxyurea—psoriasis	0.000229	0.00121	CcSEcCtD
Teniposide—Pancytopenia—Methotrexate—psoriasis	0.000229	0.0012	CcSEcCtD
Teniposide—Hypotension—Mycophenolate mofetil—psoriasis	0.000226	0.00119	CcSEcCtD
Teniposide—Oedema—Prednisolone—psoriasis	0.000225	0.00119	CcSEcCtD
Teniposide—Neutropenia—Methotrexate—psoriasis	0.000225	0.00119	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000224	0.00163	CbGpPWpGaD
Teniposide—TOP2A—Levonorgestrel—Hydrocortisone—psoriasis	0.000223	0.134	CbGdCrCtD
Teniposide—TOP2A—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000222	0.00162	CbGpPWpGaD
Teniposide—Dyspnoea—Cyclosporine—psoriasis	0.000221	0.00116	CcSEcCtD
Teniposide—Oedema—Hydrocortisone—psoriasis	0.00022	0.00116	CcSEcCtD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	0.00022	0.00161	CbGpPWpGaD
Teniposide—Tachycardia—Prednisolone—psoriasis	0.00022	0.00116	CcSEcCtD
Teniposide—Asthenia—Mycophenolic acid—psoriasis	0.00022	0.00116	CcSEcCtD
Teniposide—Hypertension—Triamcinolone—psoriasis	0.000219	0.00116	CcSEcCtD
Teniposide—Infection—Hydrocortisone—psoriasis	0.000219	0.00115	CcSEcCtD
Teniposide—Hyperhidrosis—Prednisolone—psoriasis	0.000218	0.00115	CcSEcCtD
Teniposide—Nausea—Hydroxyurea—psoriasis	0.000217	0.00114	CcSEcCtD
Teniposide—Pruritus—Mycophenolic acid—psoriasis	0.000217	0.00114	CcSEcCtD
Teniposide—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000215	0.00113	CcSEcCtD
Teniposide—Decreased appetite—Cyclosporine—psoriasis	0.000215	0.00113	CcSEcCtD
Teniposide—Tachycardia—Hydrocortisone—psoriasis	0.000215	0.00113	CcSEcCtD
Teniposide—Flushing—Prednisone—psoriasis	0.000214	0.00113	CcSEcCtD
Teniposide—Hyperhidrosis—Hydrocortisone—psoriasis	0.000213	0.00112	CcSEcCtD
Teniposide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00021	0.00111	CcSEcCtD
Teniposide—Anorexia—Hydrocortisone—psoriasis	0.00021	0.00111	CcSEcCtD
Teniposide—Diarrhoea—Mycophenolic acid—psoriasis	0.00021	0.0011	CcSEcCtD
Teniposide—Stomatitis—Methotrexate—psoriasis	0.000209	0.0011	CcSEcCtD
Teniposide—Oedema—Triamcinolone—psoriasis	0.000207	0.00109	CcSEcCtD
Teniposide—Arrhythmia—Prednisone—psoriasis	0.000206	0.00109	CcSEcCtD
Teniposide—Infection—Triamcinolone—psoriasis	0.000206	0.00108	CcSEcCtD
Teniposide—Sweating—Methotrexate—psoriasis	0.000206	0.00108	CcSEcCtD
Teniposide—Hypotension—Hydrocortisone—psoriasis	0.000206	0.00108	CcSEcCtD
Teniposide—Feeling abnormal—Cyclosporine—psoriasis	0.000204	0.00108	CcSEcCtD
Teniposide—Alopecia—Prednisone—psoriasis	0.000204	0.00107	CcSEcCtD
Teniposide—Gastrointestinal pain—Cyclosporine—psoriasis	0.000203	0.00107	CcSEcCtD
Teniposide—Tachycardia—Triamcinolone—psoriasis	0.000202	0.00107	CcSEcCtD
Teniposide—Hyperhidrosis—Triamcinolone—psoriasis	0.0002	0.00106	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—TNF—psoriasis	0.0002	0.00146	CbGpPWpGaD
Teniposide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000199	0.00105	CcSEcCtD
Teniposide—Hypertension—Dexamethasone—psoriasis	0.000199	0.00105	CcSEcCtD
Teniposide—Hypertension—Betamethasone—psoriasis	0.000199	0.00105	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—PTTG1—psoriasis	0.000198	0.00145	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000198	0.00104	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—VDR—psoriasis	0.000197	0.00144	CbGpPWpGaD
Teniposide—Urticaria—Cyclosporine—psoriasis	0.000197	0.00104	CcSEcCtD
Teniposide—Body temperature increased—Cyclosporine—psoriasis	0.000196	0.00103	CcSEcCtD
Teniposide—Abdominal pain—Cyclosporine—psoriasis	0.000196	0.00103	CcSEcCtD
Teniposide—Vomiting—Mycophenolic acid—psoriasis	0.000195	0.00103	CcSEcCtD
Teniposide—Haemoglobin—Methotrexate—psoriasis	0.000194	0.00102	CcSEcCtD
Teniposide—Rash—Mycophenolic acid—psoriasis	0.000193	0.00102	CcSEcCtD
Teniposide—Dermatitis—Mycophenolic acid—psoriasis	0.000193	0.00102	CcSEcCtD
Teniposide—Haemorrhage—Methotrexate—psoriasis	0.000193	0.00102	CcSEcCtD
Teniposide—Urticaria—Mycophenolate mofetil—psoriasis	0.000192	0.00101	CcSEcCtD
Teniposide—Headache—Mycophenolic acid—psoriasis	0.000192	0.00101	CcSEcCtD
Teniposide—Decreased appetite—Hydrocortisone—psoriasis	0.000191	0.00101	CcSEcCtD
Teniposide—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000191	0.00101	CcSEcCtD
Teniposide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000191	0.00101	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000189	0.00138	CbGpPWpGaD
Teniposide—Oedema—Betamethasone—psoriasis	0.000188	0.000991	CcSEcCtD
Teniposide—Oedema—Dexamethasone—psoriasis	0.000188	0.000991	CcSEcCtD
Teniposide—Infection—Betamethasone—psoriasis	0.000187	0.000984	CcSEcCtD
Teniposide—Infection—Dexamethasone—psoriasis	0.000187	0.000984	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000187	0.00136	CbGpPWpGaD
Teniposide—Feeling abnormal—Prednisolone—psoriasis	0.000186	0.000979	CcSEcCtD
Teniposide—Anaemia—Prednisone—psoriasis	0.000186	0.000977	CcSEcCtD
Teniposide—Dyspnoea—Triamcinolone—psoriasis	0.000185	0.000974	CcSEcCtD
Teniposide—Agitation—Prednisone—psoriasis	0.000184	0.000972	CcSEcCtD
Teniposide—Thrombocytopenia—Dexamethasone—psoriasis	0.000184	0.00097	CcSEcCtD
Teniposide—Thrombocytopenia—Betamethasone—psoriasis	0.000184	0.00097	CcSEcCtD
Teniposide—Tachycardia—Betamethasone—psoriasis	0.000184	0.000967	CcSEcCtD
Teniposide—Tachycardia—Dexamethasone—psoriasis	0.000184	0.000967	CcSEcCtD
Teniposide—Hypersensitivity—Cyclosporine—psoriasis	0.000183	0.000961	CcSEcCtD
Teniposide—Nausea—Mycophenolic acid—psoriasis	0.000182	0.000958	CcSEcCtD
Teniposide—Hyperhidrosis—Dexamethasone—psoriasis	0.000182	0.000958	CcSEcCtD
Teniposide—Hyperhidrosis—Betamethasone—psoriasis	0.000182	0.000958	CcSEcCtD
Teniposide—Feeling abnormal—Hydrocortisone—psoriasis	0.000181	0.000956	CcSEcCtD
Teniposide—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00018	0.000948	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—LEP—psoriasis	0.00018	0.00131	CbGpPWpGaD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000179	0.00131	CbGpPWpGaD
Teniposide—Anorexia—Betamethasone—psoriasis	0.000179	0.000944	CcSEcCtD
Teniposide—Anorexia—Dexamethasone—psoriasis	0.000179	0.000944	CcSEcCtD
Teniposide—Urticaria—Prednisolone—psoriasis	0.000179	0.000943	CcSEcCtD
Teniposide—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000178	0.000938	CcSEcCtD
Teniposide—Asthenia—Cyclosporine—psoriasis	0.000178	0.000936	CcSEcCtD
Teniposide—Hypotension—Betamethasone—psoriasis	0.000176	0.000926	CcSEcCtD
Teniposide—Hypotension—Dexamethasone—psoriasis	0.000176	0.000926	CcSEcCtD
Teniposide—Pruritus—Cyclosporine—psoriasis	0.000175	0.000923	CcSEcCtD
Teniposide—Urticaria—Hydrocortisone—psoriasis	0.000175	0.000921	CcSEcCtD
Teniposide—Abdominal pain—Hydrocortisone—psoriasis	0.000174	0.000917	CcSEcCtD
Teniposide—Body temperature increased—Hydrocortisone—psoriasis	0.000174	0.000917	CcSEcCtD
Teniposide—Asthenia—Mycophenolate mofetil—psoriasis	0.000173	0.000913	CcSEcCtD
Teniposide—Hypertension—Prednisone—psoriasis	0.000173	0.000913	CcSEcCtD
Teniposide—Chills—Methotrexate—psoriasis	0.000173	0.000911	CcSEcCtD
Teniposide—Pruritus—Mycophenolate mofetil—psoriasis	0.000171	0.000901	CcSEcCtD
Teniposide—Feeling abnormal—Triamcinolone—psoriasis	0.000171	0.0009	CcSEcCtD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	0.00017	0.00124	CbGpPWpGaD
Teniposide—Alopecia—Methotrexate—psoriasis	0.00017	0.000897	CcSEcCtD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00017	0.00124	CbGpPWpGaD
Teniposide—Diarrhoea—Cyclosporine—psoriasis	0.000169	0.000893	CcSEcCtD
Teniposide—Hypersensitivity—Prednisolone—psoriasis	0.000166	0.000875	CcSEcCtD
Teniposide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000165	0.000871	CcSEcCtD
Teniposide—Urticaria—Triamcinolone—psoriasis	0.000165	0.000868	CcSEcCtD
Teniposide—Body temperature increased—Triamcinolone—psoriasis	0.000164	0.000863	CcSEcCtD
Teniposide—Oedema—Prednisone—psoriasis	0.000164	0.000863	CcSEcCtD
Teniposide—Decreased appetite—Betamethasone—psoriasis	0.000164	0.000861	CcSEcCtD
Teniposide—Decreased appetite—Dexamethasone—psoriasis	0.000164	0.000861	CcSEcCtD
Teniposide—Infection—Prednisone—psoriasis	0.000163	0.000857	CcSEcCtD
Teniposide—Hypersensitivity—Hydrocortisone—psoriasis	0.000162	0.000854	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—LEP—psoriasis	0.000162	0.00118	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—IL6—psoriasis	0.000161	0.00118	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.00016	0.00117	CbGpPWpGaD
Teniposide—Tachycardia—Prednisone—psoriasis	0.00016	0.000842	CcSEcCtD
Teniposide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000159	0.00116	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—CARM1—psoriasis	0.000159	0.00116	CbGpPWpGaD
Teniposide—Hyperhidrosis—Prednisone—psoriasis	0.000158	0.000834	CcSEcCtD
Teniposide—Asthenia—Hydrocortisone—psoriasis	0.000158	0.000832	CcSEcCtD
Teniposide—Vomiting—Cyclosporine—psoriasis	0.000158	0.00083	CcSEcCtD
Teniposide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000157	0.00114	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000157	0.00114	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—PPARG—psoriasis	0.000156	0.00114	CbGpPWpGaD
Teniposide—Rash—Cyclosporine—psoriasis	0.000156	0.000823	CcSEcCtD
Teniposide—Anorexia—Prednisone—psoriasis	0.000156	0.000823	CcSEcCtD
Teniposide—Dermatitis—Cyclosporine—psoriasis	0.000156	0.000822	CcSEcCtD
Teniposide—Pruritus—Hydrocortisone—psoriasis	0.000156	0.000821	CcSEcCtD
Teniposide—Headache—Cyclosporine—psoriasis	0.000155	0.000818	CcSEcCtD
Teniposide—Anaemia—Methotrexate—psoriasis	0.000155	0.000817	CcSEcCtD
Teniposide—Feeling abnormal—Betamethasone—psoriasis	0.000155	0.000817	CcSEcCtD
Teniposide—Feeling abnormal—Dexamethasone—psoriasis	0.000155	0.000817	CcSEcCtD
Teniposide—Gastrointestinal pain—Betamethasone—psoriasis	0.000154	0.00081	CcSEcCtD
Teniposide—Gastrointestinal pain—Dexamethasone—psoriasis	0.000154	0.00081	CcSEcCtD
Teniposide—Vomiting—Mycophenolate mofetil—psoriasis	0.000154	0.000809	CcSEcCtD
Teniposide—Hypersensitivity—Triamcinolone—psoriasis	0.000153	0.000805	CcSEcCtD
Teniposide—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000153	0.00111	CbGpPWpGaD
Teniposide—Rash—Mycophenolate mofetil—psoriasis	0.000152	0.000803	CcSEcCtD
Teniposide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000152	0.000802	CcSEcCtD
Teniposide—Headache—Mycophenolate mofetil—psoriasis	0.000151	0.000797	CcSEcCtD
Teniposide—Diarrhoea—Hydrocortisone—psoriasis	0.000151	0.000794	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—NOS2—psoriasis	0.000151	0.0011	CbGpPWpGaD
Teniposide—Leukopenia—Methotrexate—psoriasis	0.00015	0.000791	CcSEcCtD
Teniposide—Urticaria—Dexamethasone—psoriasis	0.000149	0.000787	CcSEcCtD
Teniposide—Urticaria—Betamethasone—psoriasis	0.000149	0.000787	CcSEcCtD
Teniposide—NCOA3—Metabolism—CARM1—psoriasis	0.000149	0.00109	CbGpPWpGaD
Teniposide—Asthenia—Triamcinolone—psoriasis	0.000149	0.000783	CcSEcCtD
Teniposide—Abdominal pain—Betamethasone—psoriasis	0.000149	0.000783	CcSEcCtD
Teniposide—Body temperature increased—Betamethasone—psoriasis	0.000149	0.000783	CcSEcCtD
Teniposide—Body temperature increased—Dexamethasone—psoriasis	0.000149	0.000783	CcSEcCtD
Teniposide—Abdominal pain—Dexamethasone—psoriasis	0.000149	0.000783	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—LEP—psoriasis	0.000148	0.00108	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	0.000148	0.00108	CbGpPWpGaD
Teniposide—Nausea—Cyclosporine—psoriasis	0.000147	0.000775	CcSEcCtD
Teniposide—Pruritus—Triamcinolone—psoriasis	0.000147	0.000773	CcSEcCtD
Teniposide—Nausea—Mycophenolate mofetil—psoriasis	0.000144	0.000756	CcSEcCtD
Teniposide—Chest pain—Methotrexate—psoriasis	0.000143	0.000752	CcSEcCtD
Teniposide—Decreased appetite—Prednisone—psoriasis	0.000142	0.00075	CcSEcCtD
Teniposide—Rash—Prednisolone—psoriasis	0.000142	0.000749	CcSEcCtD
Teniposide—Dermatitis—Prednisolone—psoriasis	0.000142	0.000748	CcSEcCtD
Teniposide—Headache—Prednisolone—psoriasis	0.000141	0.000744	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—PPARG—psoriasis	0.000141	0.00103	CbGpPWpGaD
Teniposide—Vomiting—Hydrocortisone—psoriasis	0.00014	0.000737	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.00014	0.00102	CbGpPWpGaD
Teniposide—Rash—Hydrocortisone—psoriasis	0.000139	0.000731	CcSEcCtD
Teniposide—Dermatitis—Hydrocortisone—psoriasis	0.000139	0.000731	CcSEcCtD
Teniposide—Confusional state—Methotrexate—psoriasis	0.000138	0.000727	CcSEcCtD
Teniposide—Headache—Hydrocortisone—psoriasis	0.000138	0.000727	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—PPARG—psoriasis	0.000137	0.001	CbGpPWpGaD
Teniposide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000137	0.001	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TYK2—psoriasis	0.000137	0.000999	CbGpPWpGaD
Teniposide—Infection—Methotrexate—psoriasis	0.000136	0.000716	CcSEcCtD
Teniposide—Feeling abnormal—Prednisone—psoriasis	0.000135	0.000711	CcSEcCtD
Teniposide—Asthenia—Betamethasone—psoriasis	0.000135	0.000711	CcSEcCtD
Teniposide—Asthenia—Dexamethasone—psoriasis	0.000135	0.000711	CcSEcCtD
Teniposide—Thrombocytopenia—Methotrexate—psoriasis	0.000134	0.000706	CcSEcCtD
Teniposide—Gastrointestinal pain—Prednisone—psoriasis	0.000134	0.000706	CcSEcCtD
Teniposide—Nausea—Prednisolone—psoriasis	0.000134	0.000705	CcSEcCtD
Teniposide—Pruritus—Betamethasone—psoriasis	0.000133	0.000701	CcSEcCtD
Teniposide—Pruritus—Dexamethasone—psoriasis	0.000133	0.000701	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000133	0.000967	CbGpPWpGaD
Teniposide—Hyperhidrosis—Methotrexate—psoriasis	0.000132	0.000697	CcSEcCtD
Teniposide—Vomiting—Triamcinolone—psoriasis	0.000132	0.000694	CcSEcCtD
Teniposide—Nausea—Hydrocortisone—psoriasis	0.000131	0.000689	CcSEcCtD
Teniposide—Rash—Triamcinolone—psoriasis	0.000131	0.000689	CcSEcCtD
Teniposide—Dermatitis—Triamcinolone—psoriasis	0.000131	0.000688	CcSEcCtD
Teniposide—Anorexia—Methotrexate—psoriasis	0.00013	0.000687	CcSEcCtD
Teniposide—Urticaria—Prednisone—psoriasis	0.00013	0.000686	CcSEcCtD
Teniposide—Headache—Triamcinolone—psoriasis	0.00013	0.000684	CcSEcCtD
Teniposide—Body temperature increased—Prednisone—psoriasis	0.000129	0.000682	CcSEcCtD
Teniposide—Abdominal pain—Prednisone—psoriasis	0.000129	0.000682	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	0.000129	0.000944	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—PPARG—psoriasis	0.000129	0.000943	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000129	0.000939	CbGpPWpGaD
Teniposide—Diarrhoea—Dexamethasone—psoriasis	0.000129	0.000678	CcSEcCtD
Teniposide—Diarrhoea—Betamethasone—psoriasis	0.000129	0.000678	CcSEcCtD
Teniposide—Hypotension—Methotrexate—psoriasis	0.000128	0.000674	CcSEcCtD
Teniposide—NCOA1—Metabolism—CARM1—psoriasis	0.000124	0.000901	CbGpPWpGaD
Teniposide—Nausea—Triamcinolone—psoriasis	0.000123	0.000649	CcSEcCtD
Teniposide—Dyspnoea—Methotrexate—psoriasis	0.000122	0.000643	CcSEcCtD
Teniposide—Hypersensitivity—Prednisone—psoriasis	0.000121	0.000636	CcSEcCtD
Teniposide—Vomiting—Betamethasone—psoriasis	0.00012	0.00063	CcSEcCtD
Teniposide—Vomiting—Dexamethasone—psoriasis	0.00012	0.00063	CcSEcCtD
Teniposide—Decreased appetite—Methotrexate—psoriasis	0.000119	0.000627	CcSEcCtD
Teniposide—Rash—Betamethasone—psoriasis	0.000119	0.000625	CcSEcCtD
Teniposide—Rash—Dexamethasone—psoriasis	0.000119	0.000625	CcSEcCtD
Teniposide—Dermatitis—Dexamethasone—psoriasis	0.000118	0.000624	CcSEcCtD
Teniposide—Dermatitis—Betamethasone—psoriasis	0.000118	0.000624	CcSEcCtD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000118	0.000863	CbGpPWpGaD
Teniposide—Headache—Dexamethasone—psoriasis	0.000118	0.000621	CcSEcCtD
Teniposide—Headache—Betamethasone—psoriasis	0.000118	0.000621	CcSEcCtD
Teniposide—Asthenia—Prednisone—psoriasis	0.000118	0.000619	CcSEcCtD
Teniposide—Pruritus—Prednisone—psoriasis	0.000116	0.00061	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000115	0.000842	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TYK2—psoriasis	0.000113	0.000827	CbGpPWpGaD
Teniposide—Feeling abnormal—Methotrexate—psoriasis	0.000113	0.000594	CcSEcCtD
Teniposide—Diarrhoea—Prednisone—psoriasis	0.000112	0.00059	CcSEcCtD
Teniposide—Gastrointestinal pain—Methotrexate—psoriasis	0.000112	0.00059	CcSEcCtD
Teniposide—Nausea—Dexamethasone—psoriasis	0.000112	0.000589	CcSEcCtD
Teniposide—Nausea—Betamethasone—psoriasis	0.000112	0.000589	CcSEcCtD
Teniposide—Urticaria—Methotrexate—psoriasis	0.000109	0.000573	CcSEcCtD
Teniposide—Abdominal pain—Methotrexate—psoriasis	0.000108	0.00057	CcSEcCtD
Teniposide—Body temperature increased—Methotrexate—psoriasis	0.000108	0.00057	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—NFKB1—psoriasis	0.000107	0.000779	CbGpPWpGaD
Teniposide—Vomiting—Prednisone—psoriasis	0.000104	0.000549	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000104	0.000758	CbGpPWpGaD
Teniposide—Rash—Prednisone—psoriasis	0.000103	0.000544	CcSEcCtD
Teniposide—Dermatitis—Prednisone—psoriasis	0.000103	0.000544	CcSEcCtD
Teniposide—Headache—Prednisone—psoriasis	0.000103	0.000541	CcSEcCtD
Teniposide—Hypersensitivity—Methotrexate—psoriasis	0.000101	0.000531	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.0001	0.00073	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—JUN—psoriasis	9.98e-05	0.000728	CbGpPWpGaD
Teniposide—Asthenia—Methotrexate—psoriasis	9.82e-05	0.000517	CcSEcCtD
Teniposide—Nausea—Prednisone—psoriasis	9.73e-05	0.000513	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—VEGFA—psoriasis	9.69e-05	0.000707	CbGpPWpGaD
Teniposide—Pruritus—Methotrexate—psoriasis	9.69e-05	0.00051	CcSEcCtD
Teniposide—ABCG2—Metabolism—NDUFA5—psoriasis	9.61e-05	0.000701	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—STAT3—psoriasis	9.59e-05	0.0007	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—VDR—psoriasis	9.49e-05	0.000692	CbGpPWpGaD
Teniposide—Diarrhoea—Methotrexate—psoriasis	9.37e-05	0.000493	CcSEcCtD
Teniposide—NCOA3—Metabolism—CAT—psoriasis	9.19e-05	0.00067	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.08e-05	0.000663	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—PCNA—psoriasis	9.04e-05	0.000659	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	8.93e-05	0.000651	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NFKB1—psoriasis	8.83e-05	0.000644	CbGpPWpGaD
Teniposide—Vomiting—Methotrexate—psoriasis	8.7e-05	0.000459	CcSEcCtD
Teniposide—Rash—Methotrexate—psoriasis	8.63e-05	0.000455	CcSEcCtD
Teniposide—Dermatitis—Methotrexate—psoriasis	8.62e-05	0.000454	CcSEcCtD
Teniposide—Headache—Methotrexate—psoriasis	8.58e-05	0.000452	CcSEcCtD
Teniposide—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	8.52e-05	0.000621	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TNF—psoriasis	8.3e-05	0.000606	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP2S1—psoriasis	8.17e-05	0.000596	CbGpPWpGaD
Teniposide—Nausea—Methotrexate—psoriasis	8.13e-05	0.000428	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—PCNA—psoriasis	8.08e-05	0.000589	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—VEGFA—psoriasis	8.01e-05	0.000585	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—STAT3—psoriasis	7.93e-05	0.000579	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.79e-05	0.000568	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CAT—psoriasis	7.6e-05	0.000554	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—APOE—psoriasis	7.14e-05	0.000521	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NDUFA5—psoriasis	6.88e-05	0.000502	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TNF—psoriasis	6.87e-05	0.000501	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.86e-05	0.000501	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—IL6—psoriasis	6.7e-05	0.000489	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PPARG—psoriasis	6.61e-05	0.000482	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—psoriasis	6.59e-05	0.000481	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PPARG—psoriasis	6.22e-05	0.000454	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—IL6—psoriasis	6.03e-05	0.00044	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—APOE—psoriasis	5.91e-05	0.000431	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP2S1—psoriasis	5.85e-05	0.000427	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—IL6—psoriasis	5.54e-05	0.000404	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NDUFA5—psoriasis	5.32e-05	0.000388	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PPARG—psoriasis	5.14e-05	0.000375	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.96e-05	0.000362	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NDUFA5—psoriasis	4.85e-05	0.000354	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP2S1—psoriasis	4.52e-05	0.00033	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.52e-05	0.00033	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP2S1—psoriasis	4.13e-05	0.000301	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CARM1—psoriasis	3.99e-05	0.000291	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NDUFA5—psoriasis	3.2e-05	0.000233	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—psoriasis	2.97e-05	0.000217	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CARM1—psoriasis	2.86e-05	0.000208	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP2S1—psoriasis	2.72e-05	0.000198	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CAT—psoriasis	2.45e-05	0.000179	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.37e-05	0.000173	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CARM1—psoriasis	2.21e-05	0.000161	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.16e-05	0.000158	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.07e-05	0.000151	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CARM1—psoriasis	2.01e-05	0.000147	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—APOE—psoriasis	1.91e-05	0.000139	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.88e-05	0.000137	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CAT—psoriasis	1.76e-05	0.000128	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PPARG—psoriasis	1.66e-05	0.000121	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—APOE—psoriasis	1.37e-05	9.96e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CAT—psoriasis	1.36e-05	9.91e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CARM1—psoriasis	1.33e-05	9.69e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CAT—psoriasis	1.24e-05	9.04e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPARG—psoriasis	1.19e-05	8.68e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—APOE—psoriasis	1.06e-05	7.7e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—APOE—psoriasis	9.63e-06	7.02e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PPARG—psoriasis	9.2e-06	6.71e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPARG—psoriasis	8.39e-06	6.12e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CAT—psoriasis	8.17e-06	5.96e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—APOE—psoriasis	6.35e-06	4.63e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPARG—psoriasis	5.53e-06	4.03e-05	CbGpPWpGaD
